1-4 of 4
Cecile Chabrot
Close
Sort by
Journal Articles

The French LOC Network for Primary CNS Lymphoma (PCNSL) Patients: What Can We Learn from a Large National Database?

Carole Soussain, MD PhD, Caroline Houillier, MD, Herve Ghesquieres, MD PhD, Pierre Soubeyran, MD PhD, Olivier Chinot, MD PhD, Luc Taillandier, MD PhD, Roch Houot, MD PhD, Guido Ahle, MD, Emmanuel Gyan, MD PhD, Cécile Chabrot, MD, Marie-Pierre Moles, MD, Sylvain Choquet, MD, Philippe Agape, MD, Vincent Delwail, MD, Fabrice Jardin, MD PhD, Annie Brion, MD, Gandhi Damaj, MD, Olivier Casanovas, MD, Luc Mathieu Fornecker, MD PhD, Michel Fabbro, MD, Valerie Touitou, MD PhD, Nathalie Cassoux, MD PhD, Remy Gressin, MD, Adrian Tempescul, MD, Arnaud Jaccard, MD PhD, Pascal Bourquard, MD, Franck Morschhauser, Khê Hoang-Xuan, MD PhD
Journal: Blood
Blood (2016) 128 (22): 926.
https://doi.org/10.1182/blood.V128.22.926.926
Published: 2016
Journal Articles

Frontline Therapy with the Ribvd Regimen Elicits High Clinical and Molecular Response Rates and Long PFS in Elderly Patients Mantle Cell Lymphoma (MCL); Final Results of a Prospective Phase II Trial By the Lysa Group

Remy Gressin, MD, Mary Callanan, MD PhD, Nicolas Daguindau, MD, Adrian Tempescul, MD, Sylvain Carras, Marie Pierre Moles, MD, Guillaume Cartron, MD, Roch Houot, MD PhD, Caroline Dartigeas, MD, Jean Michel Pignon, MD, Selim Corm, MD PhD, Anne Banos, MD, Christiane Mounier, MD, Jehan Dupuis, MD, Margareth Macro, MD, Joel Fleury, MD, Fabrice Jardin, MD PhD, Lionel Karlin, Pierre Feugier, MD PhD, Luc Matthieu Fornecker, MD, Cecile Chabrot, Veronique Dorvaux, MD, Krimo Bouabdallah, MD, Sandy Amorin, MD, Reda Garidi, MD, Laurent Voillat, MD, Bertrand Joly, MD, Katell Le Dû, Nadine Morineau, Hacene Zerazhi, MD, Jean Fontan, Yazid Arkam, MD, Magda Alexis, MD, Vincent Delwail, MD, Jean Pierre Vilque, MD, Loic Ysebaert, MDPhD, Steven Le Gouill, MD PhD, Ghandi Damaj, MD
Journal: Blood
Blood (2014) 124 (21): 148.
https://doi.org/10.1182/blood.V124.21.148.148
Published: 2014
Journal Articles

Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL study

Brief Report
Patrice Chevallier, Nelly Robillard, Aude Charbonnier, Emmanuel Raffoux, Sebastien Maury, Sylvain Carras, Cecile Chabrot, Cecile Fohrer, Marc Bernard, Jean-Sebastien Blade, Anne Etienne, Pascaline Talmant, Jacques Delaunay, Thierry Guillaume, Mohamad Mohty, Marie-Christine Bene, Norbert Ifrah, Herve Dombret
Journal: Blood
Blood (2012) 119 (11): 2474–2477.
https://doi.org/10.1182/blood-2011-11-390781
Published: 2012
Journal Articles

Trastuzumab (Herceptin®) for Treatment of Refractory/Relapsed HER2 Positive Adult B-ALL: Results of a Phase II GRAALL Study

Patrice Chevallier, MD, Nelly Robillard, Aude Charbonnier, Emmanuel Raffoux, MD, PhD, Sébastien Maury, Sylvain Carras, Cecile Chabrot, Cecile Fohrer, Marc Bernard, Jean-Sebastien Blade, Anne Etienne, MD, Pascaline Talmant, Jacques Delaunay, Thierry Guillaume, Mohamad Mohty, Norbert Ifrah, Herve Dombret
Journal: Blood
Blood (2011) 118 (21): 1525.
https://doi.org/10.1182/blood.V118.21.1525.1525
Published: 2011